BRIDGE PHARMA

Serial Number 98741228
602

Registration Progress

Application Filed
Sep 9, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Abandonment Notice E-Mailed - Failure to Respond
Due: Sep 07, 2025 37 days
Revival assistance for abandoned trademark

Trademark Image

BRIDGE PHARMA

Basic Information

Serial Number
98741228
Filing Date
September 9, 2024
Abandonment Date
June 20, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 7, 2025
Classes
042

Rights Holder

Bridgewest International Holdings LLC

16
Address
701 Brickell Avenue, Suite 1490
Miami, FL 33131

Ownership History

Bridgewest International Holdings LLC

Original Applicant
16
Miami, FL

Legal Representation

Attorney
Lisel M. Ferguson

USPTO Deadlines

Next Deadline
37 days remaining
Abandonment Notice E-Mailed - Failure to Respond
Due Date
September 07, 2025

Application History

14 events
Date Code Type Description Documents
Jul 7, 2025 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jul 7, 2025 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Apr 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 31, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 31, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 31, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 19, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 19, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 19, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 18, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and development of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Classification

International Classes
042